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Objective: Hypochlorous acid (HOCl), a major inorganic bactericidal compound of
innate immunity, is effective against a broad range of microorganisms. Owing to its
chemical nature, HOCl has never been used as a pharmaceutical drug for treating infec-
tion. In this article, we describe the chemical production, stabilization, and biological
activity of a pharmaceutically useful formulation of HOCl. Methods: Stabilized HOCl
is in the form of a physiologically balanced solution in 0.9% saline at a pH range of 3.5
to 4.0. Chlorine species distribution in solution is a function of pH. In aqueous solution,
HOCl is the predominant species at the pH range of 3 to 6. At pH values less than 3.5,
the solution exists as a mixture of chlorine in aqueous phase, chlorine gas, trichloride
(Cl
−
3 ), and HOCl. At pH greater than 5.5, sodium hypochlorite (NaOCl) starts to form
and becomes the predominant species in the alkaline pH. To maintain HOCl solution
in a stable form, maximize its antimicrobial activities, and minimize undesirable side
products, the pH must be maintained at 3.5 to 5. Results: Using this stabilized form of
HOCl,thepotentantimicrobialactivitiesofHOClaredemonstratedagainstawiderange
of microorganisms. The in vitro cytotoxicity profile in L929 cells and the in vivo safety
profile of HOCl in various animal models are described. Conclusion: On the basis of
the antimicrobial activity and the lack of animal toxicity, it is predicted that stabilized
HOCl has potential pharmaceutical applications in the control of soft tissue infection.
Aremarkablefeatureoftheimmunesystemisitsabilitytolaunchaneffectiveresponse
against invading pathogens by deploying a group of highly reactive chemicals, including
oxidized halogens, oxidizing radicals, and singlet oxygen.1,2
AsdepictedinFigure1,theprecursorofthesereactiveoxygenspecies(ROS)istheoxy-
genradical(O2),whichisgeneratedbyspecializedimmunecells—neutrophils,eosinophils,
mononuclear phagocytes, and B lymphocytes.1−9 Production of ROS in these cells is
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Figure 1. Aschematicrepresentationofhypochlorousacid(HOCl)productionduring
the oxidative burst process. During this process, cells utilize O2 and convert it to hy-
drogenperoxide(H2O2)usingamitochondrial-membrane–boundenzymeNADPHase.
Then,myeloperoxidasecatalyzesthereactionbetweenH2O2 andCl− togenerateHOCl.
As deregulations take place, the lumen of the phagasome progressively becomes more
acidic and leaves the bacterium within a vacuole (phagolysosome) containing MPOse
and H2O2 in a medium containing 0.1 M Cl− at estimated pH 4 to 6. During this pro-
cess, conditions are optimal for MPOse-catalyzed generation of HOCl as depicted in
this figure. On the basis of these principles, we set out to establish the conditions of
generating the stable form of HOCl (NVC-101).
accompanied by a significant rise in oxygen consumption, a series of events collectively
referred to as the oxidative burst. The primary enzyme responsible for ROS production is
a mitochondrial-membrane–bound enzyme known as respiratory burst NADPH oxidase.1
Patients with chronic granulomatous disease have oxidase defective genes, which makes
them susceptible to repeated infection.10,11 During a respiratory burst, neutrophils produce
H2O2, which is converted to HOCl by the activity of the granule enzyme myeloperoxidase
in the following reaction.12
H2O2 + Cl
− + H+ → HOCl + H2O
HOCl is known to be the major strong oxidant produced by neutrophils, and is a potent
microbicidal agent within these cells.2,10 Experimentally, it has been estimated that 106
neutrophils stimulated in vitro can produce 0.1 μM HOCl. This quantity of HOCl can
kill 1.5 × 107 Escherichia coli in less than 5 minutes.13 HOCl reacts readily with a range
of biological molecules, particularly those with thiol, thiolether, heme proteins, and amino
groups,12 andmayleadtotissueinjury.Taurine,anonessentialaminoacidnaturallyfoundat
roughly 15 mM within neutrophils acts as a scavenger molecule for HOCl via the following
mechanism, and effectively dampens the collateral damage to cellular macromolecules
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caused by HOCl.14
HOCl + NH2-C H 2-C H 2-S O 3H → Cl(1or2) N-CH2-CH2-SO3H + H2O
To date, pure HOCl has not been developed as a commercial pharmaceutical formulation
presumably because of the challenge of maintaining storage stability. In this article, we
describe a method for the preparation and stabilization of a pure form of HOCl (also
referred to as NVC-101) for potential use as a pharmaceutical agent. We show here that
when compared to the commercially available disinfectants hydrogen peroxide and sodium
hypochlorite (NaOCl), this formulation has improved in vitro antimicrobial activity and
therapeutic index. Furthermore, we present data demonstrating an excellent safety profile
for NVC-101 in animal toxicology studies. We believe the improved properties of our pure
physiologicallybalancedstabilizedformofHOClmayallowforitsuseinaclinicalsituation
such as in the treatment or prevention of infection in burn or other wounds.
MATERIALS AND METHODS
Preparation of HOCl
Reagent-grade NaOCl was purchased from J. T. Baker. Hypochlorous acid was prepared
in 154 mM NaCl by acidifying reagent-grade NaOCl to the pH range of 3.5 to 4.0 with
dilute HCl. A Beckman pH meter was used to accurately measure the final pH values.
The concentration of active total chlorine species in solution expressed as [HOCl]T (where
[HOCl]T = [HOCl] + [Cl2] + [Cl
−
3 ] + [OCl−]) in 0.9% saline was determined by converting
all the active chlorine species to OCl− with 0.1 M NaOH and measuring the concentration
of OCl−. The concentration of OCl− was determined spectrophotometrically at 292 nm
(ε = 362 M−1 cm−1)15 with an Agilent 8453 UV-visible spectrophotometer.
Microbiological materials
All microorganisms used in these studies were purchased from the American Type Culture
Collection (ATCC), grown and propagated according to the recommendations for each
strain by ATCC. Bacterial cells were harvested at stationary phase and concentrations were
determined by 10-fold dilution as direct colony count. To prepare inoculum, bacteria were
diluted in sterile saline before use to minimize the effect of broth on HOCl.
Minimum bactericidal concentration
A modification of the National Committee Consensus on Laboratory standardized protocol
“Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobi-
cally” was used in these studies. Sterile 0.9% saline at pH 3.5 to 4.0 (vehicle) was used as
the diluent. Use of such a diluent allows for the determination of the intrinsic activity of
HOCl in the absence of any interfering molecules. Specifically, each test article is diluted
using 2-fold serial dilution in acid-washed glass tubes to give a range of concentrations
from approximately 2 to 0.002 mM in a final volume of 1 mL. Each dilution is inoculated
with 5 ×105 CFU/mL test bacteria and coincubations were carried out at room temperature
for 60 minutes. At 60 minutes posttreatment, 0.1 mL of each reaction was immediately
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transferred into prelabeled 1.5-mL microfuge tubes containing 0.9 mL Dey and Engley
(D/E) neutralizer broth (Hardy Diagnostic, Santa Maria, CA). Minimum bactericidal con-
centration (MBC) is determined by plating 0.1 mL of each sample onto an agar plate. Plates
were then incubated overnight at 35˚C, and examined for colony growth. The concentration
at which there was a complete absence of colony growth is determined to be the MBC.
Comparative MBC results provide estimates of the susceptibility of various test articles
against test organisms.
Time kill
For time kill studies, 5 mL of test article at an approximate MBC concentration was inocu-
lated with approximately 106 CFU/mL of each test organism and incubated for 0, 5, 10, 15,
20,30,60,and90minutesatroomtemperature.Foreachtimepoint,0.1mLwastransferred
into 0.9 mL of D/E neutralizer broth and 0.1 mL of this mixture was plated and incubated
as previously described.
Cytotoxicity
L929(ATCCCCL-1,NCTCclone929)isaconnective-tissuecelllinederivedfromnormal
subcutaneousareolarandadiposetissueofa100-day-oldmaleC3Hmouse.L929cellswere
purchasedfromATCCandpropagatedaccordingtosupplier’srecommendations.Thesecells
were then seeded at 1.5 ×104 cells per well in 96-well plates and incubated overnight at
37˚C. On the day of testing, growth medium was aspirated from each well, and 30 μL
fresh medium was added per well. Test articles were diluted by 2-fold serial dilution using
154mMsalineatthedesiredpHforeachtestarticle.Followingthat,170μLofeachdilution
was added to each well for a total volume of 200 μL per well. After 60 minutes’ exposure
at 37˚C, test articles were replaced with 200 μL of fresh tissue culture media and incubated
for 24 hours at 37˚C. Cell viability was determined by addition of WST-8 (Dojindo, Japan)
reagent and the absorption at 450 nm read spectrophotometrically. Orange-red formazan,
which is produced by live cells, is a direct measure of cell viability in this assay.
Therapeutic index
The therapeutic Index of an antimicrobial agent is defined as the ratio of the concentration
to achieve 50% cell toxicity (CT50) to MBC.
Animal safety and toxicity studies
Ocular irritation, skin sensitization, and wound toxicology studies were performed. A pre-
liminary (non–good laboratory practice [non-GLP]) study with a development formulation
of HOCl (2.5 mM; 0.013% w/v) was carried out at the Brookdale Eye Clinic (K. Najafi,
MD, unpublished data). Dutch pigmented rabbits received either 5% ophthalmic povidone-
iodine (Betadine) (15 eyes) or the development formulation (15 eyes). Each eye received
0.1 mL of solution every 8 hours for a total of 72 hours and observations were made peri-
odically during this time. The effect of the development formulation was compared to 5%
ophthalmic-grade Betadine.
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A GLP ocular irritation study (NAMSA, Toledo, OH) was designed to determine the
potentialforocularirritationfollowingasingleinstillationintherabbit.NewZealandWhite
rabbits (5 per group) were used. Hypochlorous acid (NVC-101) was instilled in the right
eye at concentrations of 0.01%, 0.03%, and 0.1% w/v (pH 3.5). The left eyes were used as
the controls and were untreated, vehicle (saline) or positive control treated. In all cases, the
volume used was 0.1 mL, which was placed into the lower conjunctival sac. Evaluations for
irritation were made at 24, 48, and 72 hours. At 24 hours, the cornea was examined using
fluorescein stain.
GLP repeat-dose wound toxicity studies (Charles River, Spencerville, OH) were de-
signedtoprovidemaximumexposuretofull-thicknesswoundsinratsandmini-pigs.Wounds
weretreatedwithNVC-101atconcentrationsof0.01%,0.03%,and0.1%w/v(pH3.5).The
test material was applied to the wounded area directly using soaked gauze. The treated site
wascoveredforapproximately24hoursperdayfor28days.Woundsachieving75%closure
were kept open by abrasion. Parameters used to assess systemic toxicity included clinical
signs (including observations of the site), body weights, food intake, clinical chemistries
(bloodandurine),hematology,organweights,andgrossandmicroscopictissueevaluations.
RESULTS
Synthesis of hypochlorous acid
Hypochlorous acid can be synthesized by one of the 3 methods: hydrolysis of chlorine
gas (eq 1), electrolysis of salt solution (eqs 2a and 2b), and acidification of hypochlorite
(eq 3).
Cl2 + H2O  HOCl + H+ + Cl
− (1)
2Cl
− + 2e− → Cl2 (2a)
Cl2 + H2O  HOCl + H+ + Cl
− (2b)
OCl
− + H+  HOCl (3)
The limitations of using equation 1 are the inherent hazards of handling chlorine and the
difficulty in manipulation. The disadvantage of the electrolysis method (eq 2) is the diffi-
culty in controlling the target concentration of solution. Since hypochlorite is commercially
available,theuseofthemethodinequation3isthepreferredmethodandismoreconvenient,
safe, and controllable when compared to the other 2 methods.
Distribution of active chlorine species
This section discusses the distribution of active chlorine species as a function of pH in
physiologically balanced saline solution. The presence of Cl− in HOCl solution could
result in the formation of Cl2 and Cl
−
3 . The formation of Cl2 has a significant impact on the
stability of HOCl (Fig 2).
Equations 4 to 7 show the equilibria existing in HOCl/NaC1 solution.
HOCl  H+ + OCl
− pKa = 7.5 (4)
HOCl + Cl
− + H+  Cl2(aq) + H2OK 1 = 9.6 × 102 M−2 (5)
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Figure 2. Chlorine speciation profile as a function
of pH.
Cl2(aq) + Cl
−  Cl
−
3 K2 = 0.18 M−1 (6)
Cl2(aq)  Cl2(g) K3 = 10.87 atm M−1 (7)
The molar percentage of each species in physiologically balanced HOCl solution is a func-
tion of pH (Fig 2). As is shown in equation 5, low pH and high [Cl−] favors the formation
of Cl2. Once Cl2 is formed in the aqueous phase, it migrates into the headspace to reach the
equilibrium shown in equation 7. The transfer of Cl2 from the solution to the headspace of
the container results in a decrease in active chlorine concentration in solution. Therefore,
the degassing of Cl2 becomes a major path for loss of HOCl in an open system (nonsealed).
This is a potential problem for clinical use of HOCl. To stabilize the physiologically bal-
anced HOCl solution, minimizing the formation of Cl2 is essential. Figure 2 shows the
chlorine species distribution as a function of pH in accordance with the equilibria shown
in equations 4 to 7. The lines are the calculated values based on the equilibrium constants
shown in equations 4 to 7.16−19
Microbicidal effect of HOCl
Stabilized HOCl demonstrates broad-spectrum antimicrobial activity at concentrations
ranging from 0.1 to 2.8 μg/mL (Table 1).
The exception is Aspergillus niger, where a higher concentartion of HOCl
(86.6 μg/mL) was required for effective killing of the organism under the same assay con-
ditions. The overall summary of MBC findings against various microorganisms is shown
in Table 1. Similarly, differences in HOCl sensitivity among different bacteria have been
reported previously.20−22
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Table 1. Minimum bactericidal concentration (μg/mL) of
HOCl for a broad spectrum of microorganisms tested at room
temperature for 60 min
Pathogen ATCC MBC
Escherichia coli 25922 0.7
Pseudomonas aeruginosa 27853 0.35
Staphylococcus aureus 29213 0.173
Staphylococcus epidermidis 12228 0.338
Micrococcus luteus 7468 2.77
Corynebacterium amycolatum 49368 0.169
Haemophilus inﬂuenzae 49144 0.338
Proteus mirabilis 14153 0.340
Staphylococcus hominis 27844 1.4
Staphylococcus haemolyticus 29970 0.338
Staphylococcus saprophyticus 35552 0.35
Candida albicans 10231 2.7
Klebsiella pneumoniae 10031 0.7
Serratia marcescens 14756 0.169
Streptococcus pyogenes 49399 0.169
Enterobacter aerogenes 51697 0.676
Candida albicans 10231 0.17
Aspergillus niger 16404 86.6
Methicillin-resistant Staphylococcus aureus 33591 0.682
Vancomycin-resistant Enterococcus faecium 51559 2.73
ATCC indicates American Type Culture Collection; MBC, minimum bactericidal
concentration.
Time kill
Time kill is an in vitro measure of how fast a given antimicrobial can kill test bacteria.
The rate of kill by stabilized HOCl was first demonstrated at the MBC values for each
microorganism using an inoculum size of 1 × 106 mL–1 for each test bacteria (Tables 2 and
3). As it is shown in this table, majority of test organisms were killed (>99.99%) within
the first 2 minutes of exposure. Among the bacterial species tested, Streptococcus pyogenes
49399 was the only exception, which required approximately 10 minutes of exposure for
effective killing, under the same assay conditions. The killing rate of stabilized HOCl with
NaOCl and H2O2 was then determined against 3 specific test organisms—E. coli 25922, P .
aeruginosa 27853, and S. aureus 29213—at room temperature for a total of 90 miniutes.
It is worth mentioning that all these time kill studies were also performed with an in-
oculumsizeof1×106/mLforeachtestbacteria,andthecomparativeresultsaredepictedin
Table 4.
Astheresultsshow,HOClatitsMBCvaluesfordifferenttestorganisms(5.6–12.5μM)
was able to kill all 3 test bacteria in less than 1 minute, with no significant bacterial killing
effectfromitsexcipient,salineatpH4.0(datanotshown).However,thekilltimeforNaOCl
at MBC values 10 to 50 μM varied from 5 to 15 minutes for the same 3 test organisms. In
contrast, H2O2was only able to kill P . aeruginosa 27853 at 7500 μM in about 10 minutes,
but did not kill S. aureus 29213 at its highest concentration tested (20,000 μM) even up to
90 minutes’ exposure time under the same assay conditions (Fig 3).
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Table 2. Time kill for stabilized hypochlorous acid at MBC concentrations against different
pathogens at room temperature
Time kill (min), recovered CFU/mL × 102 (n =3 )
Pathogen 0 1 2 5 10 15 30 60 90
Escherichia coli 25922 0 0000 0000
Pseudomonas aeruginosa 27853 0 0000 0000
Staphylococcus aureus 29213 >6 0 0000 0000
Staphylococcus epidermidis 12228 0 0000 0000
Micrococcus luteus 7468 0 0000 0000
Corynebacterium amycolatum 49368 0 0000 0000
Haemophilus inﬂuenzae 49144 0 0000 0000
Proteus mirabilis 14153a 00000 0000
Staphylococcus hominis 27844 0 0000 0000
Staphylococcus haemolyticus 29970 0 0000 0000
Staphylococcus saprophyticus 35552 0 0000 0000
Klebsiella pneumoniae 10031 0 0000 0000
Serratia marcescens 14756 0 0000 0000
Streptococcus pyogenes 49399 >300 >300 >300 >300 >300 52 0 0 0
Enterobacter aerogenes 51697 0 0000 0000
Candida albicans 10231 0 0000 0000
Asperigillus niger 16404 >3 0 01 2 0 0 0 0 0000
Methicillin-resistant Staphylococcus aureus 33591 >3 0 0 0000 0000
Vancomycin-resistant Enterococcus faecium 51559 >3 0 0 0000 0000
Escherichia coli 25922 0 0000 0000
Comparative cell toxicity
The relative cell toxicity of HOCl, NaOCl, and H2O2 was assessed following a standard
methodusedtoexaminethecytotoxicityofliquiddisinfectants.23 Thistoxicityassayutilizes
an established adherent cell line, L929, and the end point is relative cell viability measured
by addition of WST-8 (Dojindo, Japan) colorimetric reagent. Orange-red formazan, which
is produced by live cells, is a direct measure of cell viability in this assay. Cytotoxicity was
measured using 2-fold dilutions of HOCl, NaOCl, and H2O2 as compared to untreated or
vehicle-treated control L929 cells. The CT50 was calculated for each test article, the values
for which are shown in Figure 4. The CT50 values for HOCl (15–25 μg/mL) and NaOCl
(38–42 μg/mL) were reproducible and closely matched published results for NaOCl.16
Table 3. Comparative time kill studies of HOCl, NaOCl,
and H2O2 against 3 test organisms at room temperature
for a total of 90 min
Time kill (min)
Pathogen ATCC HOCl OCl− H2O2
Escherichia coli 25922 0 <5 >90
Pseudomonas aeruginosa 27853 <1 <20 <15
Staphylococcus aureus 29213 0 <10 >90
ATCC indicates American Type Culture Collection.
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Table 4. ComparativeMBC(μM)ofHOCl,NaOCl,andH2O2 tested
against 3 organisms at room temperature for 60 min
MBC (μM)
Pathogen ATCC HOCl OCl− H2O2
Escherichia coli 25922 5.6 40 7,500
Pseudomonas aeruginosa 27853 6.2 10 >20,000
Staphylococcus aureus 29213 12.5 50 >20,000
ATCC indicates American Type Culture Collection; MBC, minimum bactericidal
concentration.
However, the CT50 values for H2O2 were more variable (5–35 μg/mL), probably due to the
chemical instability of H2O2 under these assay conditions.
Relative therapeutic index
The therapeutic indices for HOCl, NaOCl, and H2O2 were assessed using L929 cells and
3 clinically relevant bacterial strains—E. coli 25922, P . aeruginosa 27853, and S. aureus
29213. The calculated therapeutic index values for all 3 organisms are summarized in
Figure 5.
The value for stabilized HOCl is approximately 98-fold higher than that for H2O2 for
the gram-negative bacterium E. coli 25922, and more than 1000-fold higher than H2O2 for
gram-positive organisms like S. aureus 29213.
Animal safety and toxicity
Stabilized HOCl is reactive, and therefore is not persistent. To evaluate its potential toxi-
city, several well-established animal models were used. Stabilized HOCl was found to be
0 1 02 03 04 05 06 07 08 09 0 1 0 0
HOCl
OCl- 
H2O2
T
e
s
t
 
a
r
t
i
c
l
e
s
Minutes posttreatment
Staphylococcus aureus
Pseudomonas aeruginosa
Escherichia coli
Figure 3. Comparative time kill studies of HOCl, NaOCl, and H2O2 against 3
test organisms—Escherichia coli 25922, Pseudomonas aeruginosa 27853, and
Staphylococcus aureus 29213—at room temperature for total of 90 miniutes.
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Figure 4. Relativecelltoxicityofhypochlorousacid(HOCl;pH4.0),
hypochlorite(OCl−;pH10.5),andhydrogenperoxide(H2O2;pH7.0)
on L929 cells. Cytotoxicity measured in a cell proliferation assay is
expressed as the concentration (μg/mL) that reduces the cell num-
ber by 50% of vehicle-treated control. CT50 is shown as the average
of 7, 3, and 5 independent experiments (consisting of 10 different
concentrations of each test article plus/minus the standard deviation),
respectively.
nonirritating in (rabbit eye) and nonsensitizing in (guinea pig) animal models (Table 5).
No ocular irritation was observed following the instillation of a development formulation
(0.013%HOCl)intotheeyesofDutchpigmentedrabbitsevery8hoursfor72hours(datanot
shown). Stabilized HOCl at concentrations of 0.01%, 0.03%, and 0.10% w/v in a standard
Buehler-design dermal sensitization study in guinea pigs showed no evidence of dermal
Figure 5. Relative therapeutic index of hypochlorous acid
(HOCl; pH 4.0), hypochlorite (OCl−; pH 10.5), and hy-
drogen peroxide (H2O2; pH 7.0). Therapeutic index is ex-
pressed as a ratio of the CT50 concentration (μg/mL) on
L929 cells divided by the minimum bactericidal concen-
tration (μg/mL) for Staphylococcus aureus 29213, Pseu-
domonasaeruginosa27853andEscherichiacoli2592.The
higher the therapeutic index, the safer the test article will
be.
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Table 5. Safety studies with control vs stabilized HOCl in 4 different animal species
Studies Species Site applied NVC-101 (% w/v) Results
Eye irritation Rabbits Eye, Q8 for 72 h Saline
0.013
Betadine
No irritation
No irritation
Progressive irritation
Eye irritation Rabbits Eye, single
instillation
Saline
0.01, 0.03, and 0.1
No irritation
No irritation at any dose
Skin sensitization Hartley-derived
albino guinea pig
Skin Saline
0.01, 0.03, and 0.1
No sensitization
No irritation at any dose
28-Day toxicology Rat Full-thickness
wound
Saline
0.01, 0.03, and 0.1
No systemic toxicity at any
dose and histopathology
consistent with wound
healing
28-Day toxicology Mini-pig Full-thickness
wound
Saline
0.01, 0.03, and 0.1
No systemic toxicity at any
dose and histopathology
consistent with wound
healing
reaction. Similarly, 28-day toxicity studies in full-thickness wounded rats and mini-pigs
with daily application of stabilized HOCl at 0.01%, 0.03%, and 0.1% w/v together with a
24-hour occluded dressing showed no evidence of systemic toxicity. Microscopic examina-
tionofthewoundareashowedtheexpectedsignsofwoundingandsubsequentwoundrepair.
A summary of all toxicological safety results with stabilized HOCl is shown in Table 5.
DISCUSSION
ThegermicidalpropertiesofHOClhavebeenwellreported.1,10,13,20,21,24Hypochlorousacid
is widely used as a disinfectant, for example, in sanitizing wash solutions and swimming
pools. In these applications, the reactive chemical is formed in solution by the addition of
chlorine to water. Similarly, HOCl is used to treat drinking water and is formed following
addition of chlorine gas or NaOCl.
Figure 2 shows the relative molar distribution of various chlorine species in a closed
saline solution system as a function of pH. Between pH levels of 3 and 6, the predominant
species is HOCl. At higher pH, hypochlorite ion (OCl
−) is formed, whereas at lower pH,
the solution exists as a mixture of chlorine (Cl2) in solution, chlorine gas in the headspace,
and HOCl. The control of this reaction has been utilized in industrial practices to optimize
the availability of the active antimicrobial, HOCl.
In this report, stabilized HOCl is prepared by the addition of NaOCl to a solution of
sodium chloride in sterile water, followed by addition of a solution of hydrochloric acid to
form the active component, HOCl. Stabilized HOCl (referred to as NVC-101) is a dilute
solution of HOCl in 150 mM (0.9%) sodium chloride at an unbuffered pH of 3.5. The
solution is stored in inert sealed containers designed for maximum product stability.
As shown in Figure 2, in a pH range of 3 to 6 the predominant species is HOCl. At
pH values greater than 5.5, hypochlorite ion (OCl−) is formed, and around pH 7.5 (the pKa
of HOCl of the chlorine species in solution is at 50/50% mixture [HOCl/OCl−]).12 As the
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pH increases from 9.5, the concentration of OCl− in solution reaches its maximum level,
becoming 100% hypochlorite (also referred to as bleach). However, on the acidic side at pH
less than 4, the solution exists as a mixture of chlorine (Cl2) in aqueous phase, chlorine gas
in the headspace, trichloride (Cl
−
3 ), and HOCl. At pH less than 3, an appreciable amount of
Cl2 gas forms, which may cause the rapid loss of all active chlorine in an open container.
To keep the solution stable and maintain its desired activity, the pH of the solution should
remain between 3.5 and 5 and the solution should be stored in a tightly sealed container.
For the first time, we have been able to determine these conditions to stabilize HOCl and
to assess its biological properties as a pharmaceutical product.
The biological effect of HOCl on bacteria has been extensively studied.22,25,26 HOCl
has broad-spectrum antimicrobial activity and is able to kill microorganisms very rapidly.
Respiratory loss in bacterial cell membrane as a result of an irreversible reaction of HOCl
with sulfur- and heme-containing membrane enzymes and structural proteins12 lead to cell
death and nonviability.21,22,25
Topical antiseptics with a long history of use, such as NaOCl (Dakins’ solution),
hydrogen peroxide, acetic acid, and povidone-iodine remain in widespread use today. These
antimicrobialagentsusedattypicalconcentrationsarecytotoxicandimpedewoundhealing,
and so are now discouraged by some experts for use on chronic ulcers. NVC-101 is a
low-concentration, acidified, unbuffered solution of HOCl in saline. Under the conditions
of the formulation, the active ingredient is primarily HOCl in equilibrium with a small
amount of dissolved chlorine. The studies presented here have shown that stabilized HOCl
exhibits rapid, concentration-dependent activity against a wide variety of gram-negative
and gram-positive bacteria, yeast, and fungal pathogens, as long as the narrow effective pH
range is maintained. In vivo, HOCl is produced intracellularly in abundance in response to
phagocytosis of pathogens by neutrophils and plays an important role in the destruction of
pathogens.
HOCl, the active ingredient of stabilized HOCl (NVC-101), has rapid and broad-
spectrum antimicrobial activity against clinically relevant microorganisms in vitro and
in vivo. Although vegetative bacteria are more susceptible to NVC-101 than endospore-
forming bacteria and fungi (Table 1), NVC-101 is fully capable of inactivating all groups of
gram-negativeandgram-positivebacteria,yeast,andfungi,includingS.aureus,methicillin-
resistantS.aureus,vancomycin-resistantE.faecium(Table1),andBacillisanthracisspores
(data now shown). NVC-101 has been shown to be nonirritating and nonsensitizing in an-
imal models. There was no evidence of ocular irritation following a single instillation of
NVC-101intheeyesofNewZealandWhiterabbitsatconcentrationsof0.01%,0.03%,and
0.1% w/v. No ocular irritation was observed following the instillation of a development for-
mulationintheeyesofDutchpigmentedrabbitsevery8hoursfor72hours(datanotshown).
NVC-101 at concentrations of 0.01%, 0.03%, and 0.1% w/v in a standard Buehler-design
dermal sensitization study in guinea pigs showed no evidence of dermal reaction.
The active ingredient is reactive, and therefore is not persistent. Its persistence of
antimicrobial properties has not yet been tested in the in vivo wound environment. Thus,
absorption and systemic toxicity are expected to be insignificant. Therefore, in the 28-day
wound toxicity studies in rats and mini-pigs with daily application of NVC-101 at 0.01%,
0.03%, and 0.1% w/v, with 24-hour occluded dressing, there was no evidence of systemic
toxicity. Furthermore, microscopic examination of the wound area showed the expected
signs of wounding and subsequent wound repair.
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Heggers and colleagues26 have investigated the toxic effects of various concentrations
of NaOCl (at pH 7.5, this was actually a 50:50 mixture of NaOCl and HOCl) in vitro
and in vivo in the rat incision model. Concentrations used in previous studies were often
quite high and although they had antimicrobial properties, they also exhibited some local
toxicity that was not desirable. Heggers et al. conducted their experiments in the range of
concentrations they expected to be active but not toxic to the cells or detrimental to wound
healing. The concentrations evaluated were 0.25%, 0.025%, and 0.0125% w/v in the in
vitro studies and 0.25% and 0.025% w/v in the in vivo studies. Ten clinical isolates were
usedintheinvitrostudies(bothgram-positiveandgram-negativespecies).Thebactericidal
potential of the 3 concentrations was determined. All concentrations killed gram-positive
bacteriawithin30minutes,butthelowestconcentrationdidnotkillgram-negativebacteria.
Mouse fibroblasts were exposed to various concentrations of NaOCl for 10-, 20-, or 30-
minute intervals. These cells remained viable except at the highest concentration, where
cell death by 10 minutes was noted. In the incision rat model, 3 (2.5-cm) full-thickness
wounds were created on each animal. The incisions were closed and the covered gauze was
saturated every 4 hours with the NaOCl or saline. Subsets of animals were sacrificed on
days 3, 7, and 14. Tissue sections were collected. Breaking strength was measured (force
required to rupture the scar, in kilograms). The values for the breaking strength were higher
as a function of duration, but the treated and control groups were not different. This study
concludedthattheconcentrationof0.025%retainsitsbactericidalpropertywithoutcausing
injury to the fibroblast cells.
Dakins’ solution (NaOCl) has been used as an antimicrobial for decades. A study to
assessthebactericidalactivityandtoxicityof0.5%and0.1%NaOClwasundertaken.27Only
thetoxicityportionofthestudyisdiscussedhere.Theinsulttoguineapigskinwasassessed
following application of 0.5% solution of NaOCl buffered to a pH of 7.49 for up to 2 weeks
(soakedgauzeresoakedevery8hours).Theanimalsweresacrificedonday1,4,7,or14.The
hair was removed from the skin before application but the skin was intact. The application
of 0.5% solution resulted in basal cell toxicity (15% decrease in viability after 2 weeks
of treatment), and so a lower concentration of 0.1% solution was evaluated (pH 7.4). This
lowerconcentrationdidnotresultintoxicitytothebasalcells.Controlandtreatedskinsites
were similar when the microscopic morphology was evaluated. Epidermal hyperplasia and
aninflammatoryinfluxwerenotedinthetreatedanimalsat2weeks.Theauthorsconcluded
that the solutions were therapeutic candidates for thermal injury. It is important to note that
atpH7.4,thesesolutionswillhaveapproximatelyequimolarquantitiesofHOClandNaOCl.
In the present comparative studies, we have demonstrated that H2O2 and hypochlorite
(NaOCl) are effective against certain bacteria (more effective against gram negatives, but
not gram positives). However, those effective antimicrobial concentration ranges begin to
correlate with higher cytotoxicity on mammalian cells, as compared to NVC-101. This
antiseptic profile of NaOCl resemble some of the over-the-counter antiseptics: silver ni-
trates or silver ions, Betadine, and acetic acid (data not shown). Moreover, there are other
antisepticsthatarelesstoxictomammaliancellsbutatthesametimehavelowerantimicro-
bial activity (ethanol, hydrogen peroxide, and 5% mafenide acetate solution) as compared
to NVC-101 (data not shown). The Department of Health and Human Services discour-
ages the use of commonly used antiseptic solutions to treat wound infection in general and
chronic nonhealing wounds in particular because, for reasons mentioned above, their uses
are contraindicated. Therefore data presented in this study should help in selecting safer
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antimicrobial agents for wound disinfection, irrigation, and dressing. This reevaluation of
accumulated evidence is intended as a basis to help practitioners make informed decisions
for choosing the appropriate topical antimicrobial for wound care management.
As the development of bacterial resistance to antibiotics continues and controversy
regarding the use of topical antiseptics persists, the need for research and development
of new classes of antimicrobial agents that are safe and broadly effective and have low
toxicity and low propensity to induce antimicrobial resistance becomes inevitably critical.
Currently, the use of broad-spectrum topical antibiotics to treat wounds that are failing
to heal or those at risk for getting infected is not recommended by the Department of
HealthandHumanServices.28 Theserecommendationsarebasedonthefollowingreasons:
antibiotics may cause allergic reactions; especially when applied topically may have lower
tissue distribution; greater effect on endogenous microflora (disturbance of the normal
commensalmicroflora);induceresistance;andeventuallyhavereducedtherapeuticefficacy.
By the same token, antiseptics are not encouraged because of their higher toxicity, potential
development of resistance (like antibiotics), and, more important, direct impact on wound
healing process.
Efficacy of topical antimicrobial agents in the management of serious infections, for
example, biofilm- and catheter-related wounds, particularly when chronic and nonhealing,
is inconclusive. These observations vary greatly because of (a) inconsistent in vitro test
specifications, (b) use of different animal species models, (c) use of different organisms
for determining the efficacy outcome. Therefore, overall results make direct comparisons
less than ideal. While in vitro testing is required to select potential agents for clinical trials,
these models will never totally mimic in vivo conditions.
Thus, in light of published results on HOCl and data obtained in the present investi-
gations, there is enough compelling evidence to show that our new formulation of HOCl
(NVC-101), which resembles the HOCl molecule made by neutrophils during oxidative
burst (a natural defense process against invading microorganisms), could lend itself for safe
and effective treatment modalities of infection. Because of NVC-101’s broad-spectrum,
fast-acting antimicrobial activity, the chances of developing resistance would be minimal
and based on its safety profile the potential for collateral damage to infected tissues is also
very low. Therefore, in vivo experiments in a chronic infected granulating wound model
are planned to determine NVC-101’s ability to persist in a hostile environment where the
pH range may not be ideal and where inflammation may produce exudates that limit its use
as a wound care agent.
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